The Effect of Honey on Nocturnal Cough and Sleep Quality

Sponsor
Meir Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01575821
Collaborator
Ambulatory Pediatric Association (Other)
300
1
4
39
7.7

Study Details

Study Description

Brief Summary

Cough is a common symptom in pediatric practice. It can be particularly troubling to children and their parents.It often results in discomfort to the child and loss of sleep to both the child and the parent. The objective of this trial was to compare the effects on nocturnal cough and the sleep difficulty associated with URIs of a single nocturnal dose of three different honey products compared to placebo

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Eucalyptus honey
  • Dietary Supplement: Labiatae honey
  • Dietary Supplement: Citrus honey
  • Dietary Supplement: Silan date extract
N/A

Detailed Description

Cough is a common symptom in pediatric practice.As a result, children miss daycare or school and parents miss a day of work. In an attempt to threat cough, caregivers frequently administer OTC medication to their children,with their attendant risks, kack of proven efficacy and the disapproval of professional organizations such as the AAP and the FDA. The WHO has noted honey as a potential treatment for cough and cold symptoms. Honey has antioxidant properties and increases cytokine release. The objective of this trial was to compare the effects on nocturnal cough and the sleep difficulty associated with URIs of a single nocturnal dose of three different honey products compared to placebo

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Honey on Nocturnal Cough and Sleep Quality: a Double-blind, Randomized,Placebo-controlled Study
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Apr 1, 2012
Actual Study Completion Date :
Apr 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Eucalyptus honey ,

75 children

Dietary Supplement: Eucalyptus honey
Parents were instructed to administer 10 grams of theirs child treatment product (single dose) within 30 minutes of the child going to sleep.

Experimental: Labiatae honey

75 children allocated

Dietary Supplement: Labiatae honey
Parents were instructed to administer 10 grams of theirs child treatment product (single dose) within 30 minutes of the child going to sleep.

Experimental: Silan date extract (placebo)

75 children allocated

Dietary Supplement: Silan date extract
Parents were instructed to administer 10 grams of theirs child treatment product (single dose) within 30 minutes of the child going to sleep.

Experimental: Citrus honey

75 children allocated

Dietary Supplement: Citrus honey
Parents were instructed to administer 10 grams of theirs child treatment product (single dose) within 30 minutes of the child going to sleep.

Outcome Measures

Primary Outcome Measures

  1. The principal outcome measure of interest was the change in the frequency of cough between the 2 nights (before treatment and tthe night with treatment). [changes between two nights ( the night before treatment and the night with treatment)]

    Pre intervention study questionnaire: The parents were asked to complete a five item questionnaire regarding parental subjective assessments of the child's cough and sleep difficulty on the previous night.Survey responses were graded on a seven point scale ranging from extremely (6 points) to not at all (0 points). On the day following the treatment,the parent completed the same questionnaire that had been answered before the intervention, this time regarding the previous evening when the child had received the treatment.

Secondary Outcome Measures

  1. changes in the cough severity, the bothersome nature of the cough, the effect of the cough on sleep for both the child and parents between the two nights [changes between two nights ( the night before treatment and the night with treatment)]

    Assessment was been done by completing the pre and post intervention questionnaire as was described in the " primary outcome measurment".

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 1-5 years of age complying of nocturnal cough that was attributed to a URI.
Exclusion Criteria:
  • asthma,

  • pneumonia,

  • laryngotracheobronchitis,

  • sinusitis,

  • allergic rhinitis,

  • use of cough or cold medication on the night before entering the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 6 General Pediatric Community Clinics Petach-Tikva Israel 56000

Sponsors and Collaborators

  • Meir Medical Center
  • Ambulatory Pediatric Association

Investigators

  • Principal Investigator: Cohen AV Herman, Israel Clalit Health Services

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01575821
Other Study ID Numbers:
  • hermanhoney
First Posted:
Apr 12, 2012
Last Update Posted:
Apr 12, 2012
Last Verified:
Apr 1, 2012
Keywords provided by Meir Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 12, 2012